mTOR通过核转位和STAT1抑制调节NLRP3炎症酶激活
Alvaro González-Dominguez1, Shuling Zhang2, Daniel Boy-Ruiz3
1Division of Liver Diseases, Icahn School of Medicine at Mont Sinai, New York, New York, USA.
European journal of immunology
|June 11, 2025
概括
猛素的哺乳动物标 (mTOR) 调节了巨细胞中的NLRP3炎症酶激活. 用拉巴胺素抑制mTOR抑制了炎症酶的活性,为相关疾病提供了潜在的治疗策略.
科学领域:
- 免疫学 免疫学 免疫学
- 细胞生物学 细胞生物学
- 代谢性疾病 代谢性疾病
背景情况:
- NLRP3炎症酶是炎症反应的关键调解者.
- 失调的NLRP3炎症酶激活与各种疾病有关,包括代谢障碍和神经退行.
- 它作为代谢危险和压力的传感器的作用越来越被认可.
研究的目的:
- 为了研究哺乳动物的目标拉巴胺素 (mTOR) 在调节NLRP3炎症酶激活中的作用.
- 阐明mTOR影响巨细胞中NLRP3炎症酶活性的机制.
- 探索针对mTOR-NLRP3轴的治疗潜力.
主要方法:
- 使用细胞培养模型 (巨细胞) 和小鼠模型 (mTOR敲除).
- 使用脂聚糖 (LPS) 和腺三酸盐 (ATP) 刺激评估NLRP3炎症酶激活.
- 研究了蛋白质-蛋白质相互作用,核转位和基因/蛋白质表达水平.
- 使用的药理抑制剂包括拉帕米辛和弗鲁达拉宾.
主要成果:
- 在基底条件下,mTOR与NLRP3结合;在LPS/ATP刺激时,这种结合会减少.
- 拉巴胺治疗降低了mTOR的调节,并抑制了NLRP3炎症酶激活.
- mTOR淘汰小鼠的炎症组分水平降低,并且对巨细胞的NLRP3激活受损.
- LPS/ATP诱导了mTOR的核转移,增强了NLRP3的激活.
- 拉巴胺素的mTOR抑制增加了STAT1酸化,抑制了NLRP3;这种抑制被fludarabine逆转.
结论:
- mTOR在调节巨细胞核内的NLRP3炎症酶激活方面发挥着至关重要的作用.
- mTOR-NLRP3相互作用和随后的核转位是炎症酶激活的关键步骤.
- 针对mTOR,可能与STAT1调制结合,为控制NLRP3介导的炎症提供了一个有希望的治疗策略.
相关概念视频
PI3K/mTOR/AKT Signaling Pathway
3.4K
The mammalian target of rapamycin (mTOR) is a serine/threonine kinase that regulates growth, proliferation, and cell survival in response to hormones, growth factors, or nutrient availability. This kinase exists in two structurally and functionally distinct forms: mTOR complex 1 (mTORC1) and mTOR complex 2 (mTORC2). The first form (mTORC1) is composed of a rapamycin-sensitive Raptor and proline-rich Akt substrate, PRAS40. In contrast, mTORC2 consists of a...
3.4K
mTOR Signaling and Cancer Progression
3.8K
The mammalian target of rapamycin or mTOR protein was discovered in 1994 due to its direct interaction with rapamycin. The protein gets its name from a yeast homolog called TOR. The mTOR protein complex in mammalian cells plays a major role in balancing anabolic processes such as the synthesis of proteins, lipids, and nucleotides and catabolic processes, such as autophagy in response to environmental cues, such as availability of nutrients and growth factors.
The mTOR pathway or the...
The mTOR pathway or the...
3.8K
The JAK-STAT Signaling Pathway
8.7K
Several cytokine receptors have tightly bound Janus kinase or JAK proteins attached at their cytosolic tail. Small signaling molecules such as cytokines, growth hormones, or prolactins bind to the cytokine receptors and initiate their dimerization. The dimerization brings the cytosolic JAKs together that trans-phosphorylate and activates each other. The activated JAKs now phosphorylate cytosolic tails of the cytokine receptors, which serve as binding sites for adaptor proteins such as SH2...
8.7K
NF-κB-dependent Signaling Pathway
7.3K
The transcription factor NF-κB was discovered in 1986 in the lab of Nobel laureate Professor David Baltimore, for its interaction with the immunoglobulin light chain enhancer in B-cells. After more than three decades of study, it is now evident that NF-κB regulates the expression of over 100 genes. Most of these genes play an essential role in the innate and adaptive immune responses as well as the inflammatory responses of animals.
NF-κB-dependent Signaling Mechanism
The...
NF-κB-dependent Signaling Mechanism
The...
7.3K
Regulation of Nuclear Protein Sorting
2.4K
Nuclear protein sorting regulates nucleus composition and gene expression, crucial for determining the fate of a eukaryotic cell. Hence, the entry and exit of molecules across the nuclear envelope is a tightly controlled process. Nuclear protein sorting can be inhibited by one of the following ways: 1) masking cargo signal sequences, 2) modifying the nuclear receptor's affinity for cargo, 3) controlling the nuclear pore size, 4) retaining the cargo during its transit to the cytosol or the...
2.4K
Regulation of the Unfolded Protein Response
2.4K
Inositol-requiring kinase one or IRE1 is the most conserved eukaryotic unfolded protein response (UPR) receptor. It is a type I transmembrane protein kinase receptor with a distinctive site-specific RNase activity. As the binding mechanics of the misfolded proteins with the N-terminal domain of IRE-1 are unclear, three binding models — direct, indirect, and allosteric -- are proposed for receptor activation. Nevertheless, it is known that once a misfolded protein associates with IRE1, it...
2.4K


